...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zhlcf

,,,Gents...Ladies,,,,,with the vast amount of disinformation in this digital world of currencies and other ,,coupled with those who like to conjur,,be advised if the Zenith team say their shares are not tradable OTC you best believe their reply,,,someone will be left holding 2 kbs of worthless data,,,jmo.

Share
New Message
Please login to post a reply